Mayne Pharma Group Stock Technical Analysis
| MAYNF Stock | USD 3.10 0.10 3.33% |
As of the 12th of December 2024, Mayne Pharma secures the Mean Deviation of 1.47, risk adjusted performance of 0.0524, and Standard Deviation of 4.18. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mayne Pharma Group, as well as the relationship between them. Please verify Mayne Pharma Group standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Mayne Pharma Group is priced some-what accurately, providing market reflects its recent price of 3.1 per share. Given that Mayne Pharma Group has information ratio of 0.034, we recommend you to check Mayne Pharma's last-minute market performance to make sure the company can sustain itself at a future point.
Mayne Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mayne, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MayneMayne |
Mayne Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Mayne Pharma Group Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Mayne Pharma Group volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Mayne Pharma Group Trend Analysis
Use this graph to draw trend lines for Mayne Pharma Group. You can use it to identify possible trend reversals for Mayne Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Mayne Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Mayne Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Mayne Pharma Group applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Mayne Pharma Group will continue generating value for investors. It has 122 observation points and a regression sum of squares at 6.88, which is the sum of squared deviations for the predicted Mayne Pharma price change compared to its average price change.About Mayne Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Mayne Pharma Group on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Mayne Pharma Group based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Mayne Pharma Group price pattern first instead of the macroeconomic environment surrounding Mayne Pharma Group. By analyzing Mayne Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Mayne Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Mayne Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Mayne Pharma December 12, 2024 Technical Indicators
Most technical analysis of Mayne help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mayne from various momentum indicators to cycle indicators. When you analyze Mayne charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0524 | |||
| Market Risk Adjusted Performance | 1.75 | |||
| Mean Deviation | 1.47 | |||
| Coefficient Of Variation | 1647.12 | |||
| Standard Deviation | 4.18 | |||
| Variance | 17.48 | |||
| Information Ratio | 0.034 | |||
| Jensen Alpha | 0.2295 | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | 1.74 | |||
| Maximum Drawdown | 36.26 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 4.94 | |||
| Skewness | 4.35 | |||
| Kurtosis | 30.47 |
Complementary Tools for Mayne Pink Sheet analysis
When running Mayne Pharma's price analysis, check to measure Mayne Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mayne Pharma is operating at the current time. Most of Mayne Pharma's value examination focuses on studying past and present price action to predict the probability of Mayne Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mayne Pharma's price. Additionally, you may evaluate how the addition of Mayne Pharma to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |